PetMed Express director granted 55,555 restricted shares

Mennen Justin L. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Mennen Justin L. reported acquisition or exercise transactions in this Form 4 filing.

PetMed Express Inc. director Justin L. Mennen received a grant of 55,555 shares of Common Stock as a restricted stock award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan. These shares vest in full on August 11, 2027, subject to his continued service on the Board of Directors.

After this award, Mennen directly holds 98,274 shares of PetMed Express common stock.

Insider Trade Summary

Grant/Award: 55,555 shares

Grant/Award 1 txn

Insider Mennen Justin L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	55,555	$0.00	$0.00

Holdings After Transaction: Common Stock — 98,274 shares (Direct)

Footnotes (1)

1. F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Key Figures

Restricted stock award: 55,555 shares Post-transaction holdings: 98,274 shares Vesting date: August 11, 2027 +1 more

4 metrics

Restricted stock award 55,555 shares Restricted stock granted to Justin L. Mennen on 2026-08-11

Post-transaction holdings 98,274 shares Total Common Stock directly held by Justin L. Mennen after award

Vesting date August 11, 2027 All 55,555 restricted shares vest on this date, subject to continued service

Grant price per share $0.0000 Stated transaction price per share for the restricted stock award

Key Terms

restricted stock award, 2024 Omnibus Incentive Plan, continued service

3 terms

restricted stock award financial

"Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

2024 Omnibus Incentive Plan financial

"award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests"

continued service financial

"vests as to all granted shares on August 11, 2027, subject to continued service on the Board"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did PetMed Express (PETS) grant to director Justin L. Mennen?

PetMed Express granted Justin L. Mennen a restricted stock award of 55,555 shares of Common Stock. The award was made under the 2024 Omnibus Incentive Plan at a stated price of $0.0000 per share.

When do Justin L. Mennen’s new PETS restricted shares vest?

The 55,555 restricted shares granted to Justin L. Mennen vest as to all granted shares on August 11, 2027, subject to his continued service on the PetMed Express Board of Directors until that date.

How many PetMed Express (PETS) shares does Justin L. Mennen own after this grant?

Following the restricted stock award, Justin L. Mennen directly holds 98,274 shares of PetMed Express Common Stock. This figure reflects his total direct ownership reported after the August 11, 2026 transaction.

Was Justin L. Mennen’s PETS stock grant a market purchase or a compensation award?

The transaction was reported with code A, indicating a grant, award, or other acquisition of shares. Footnote disclosure confirms it is a restricted stock award under the 2024 Omnibus Incentive Plan, not a market purchase.

Is Justin L. Mennen’s PETS stock award tied to any performance or only service conditions?

The disclosure states the 55,555 restricted shares vest on August 11, 2027, subject to continued service on the Board of Directors. It does not describe additional performance conditions beyond continued Board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mennen Justin L.

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		A		55,555(1)	A	$0	98,274	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Remarks:

	/s/ Justin L. Mennen	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)